Investment
Features
FeesSafety
Academy
More
Pluang+

Compare InMode Ltd (INMD) vs Health Care Select Sector SPDR Fund (XLV) Price & Performance

InMode LtdTrade
Health Care Select Sector SPDR FundTrade

Price performance (Past 24H)

Key statistics

InMode Ltd vs Health Care Select Sector SPDR Fund — how do they compare? InMode Ltd trades at $15.25 (market cap $872.08M), while Health Care Select Sector SPDR Fund trades at $168.42. The key difference: Health Care Select Sector SPDR Fund is trading nearer its 52-week high, InMode Ltd nearer its low. Which is the better fit depends on your goals.

INMDXLV
Market Cap
$872.08M
Sector
Technology
52-Week High
$16.62$168.44
52-Week Low
$12.76$131.16
Enterprise Value
$375.42M

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

InMode Ltd

INMD trades at $15.23, up 0.26% today, with a neutral technical outlook and mixed earnings history including a Q1 2026 miss. The company reported Q2 2026 revenue of $95.6 million, consistent year-over-year, and maintains a strong gross profit margin of 76.52%. Recent news highlights an unsolicited acquisition offer from Steel Partners at $16.75 per share and shareholder activism urging rejection, creating uncertainty around corporate governance.

The stock presents a value opportunity with low P/E and EV/EBITDA ratios, but risks include earnings volatility, potential acquisition fallout, and ongoing securities fraud investigations. Analyst consensus is divided between Buy and Hold ratings, reflecting cautious optimism amid near-term headwinds. Long-term growth depends on execution of international expansion and innovation in medical technologies.

Health Care Select Sector SPDR Fund

XLV, the Health Care Select Sector SPDR ETF, trades at $168.44 with a neutral daily change. Technical indicators show a bullish trend from moving averages but oscillators are neutral, with the 6-day RSI at 86.78 suggesting overbought conditions. The fund's low 0.08% expense ratio and defensive healthcare sector exposure attract steady inflows amid market volatility, as highlighted by recent ETF flow reports.

The outlook for XLV is cautiously optimistic, supported by defensive demand and strong sector earnings. Key opportunities include diversification benefits and cost efficiency, while risks involve sector-specific regulatory pressures and broader economic sensitivity. Investors should weigh the ETF's stability against potential growth limitations in a concentrated portfolio.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About InMode Ltd

InMode provides innovative medical technologies for minimally invasive surgical procedures. Its platforms use radiofrequency (RF) energy for aesthetic treatments like body contouring and skin tightening.

Read more on INMD

About Health Care Select Sector SPDR Fund

In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.

Read more on XLV